background image
1

São Paulo, May 13, 2005
­ Natura Cosméticos S.A. (Bovespa: NATU3) informs that its
shares were included in IBrX100 index and will be added to the MSCI Index - Morgan
Stanley, as per the latest index review.


Bovespa ­ IBrX100 Index
Natura Cosméticos shares were included in the IBrX100 index latest review, which is
effective from May to August 2005. Natura's weight in this index is 0.53%.
IBrX index is composed of 100 shares with highest liquidity level traded in the Brazilian
equity market and is a benchmark for the performance of pension funds and asset
management portfolios.

MSCI ­ Index
In the latest index review, 278 international securities will be added to the MSCI Index,
effective as of the close of May 31, 2005. Natura Cosméticos was added to the following
MSCI Indexes: (a) MSCI Brazil with a 0.53% weight, representing the 3
rd
greatest weight
increase among Brazilian companies; (b) MSCI Emerging Markets (EM) Latin America with
a 0.27% weight and (c) MSCI EM with a 0.05% weight.
The MSCI Index is considered a benchmark by institutional investors, based on the free
float adjusted market capitalization of each industry and country.
Natura included in IBrX100
and MSCI Indexes
background image
2
INVESTOR RELATIONS
Phone: 5511-4446-2180
Helmut Bossert,
helmutbossert@natura.net
Manager
Ricardo Capella,
ricardocapella@natura.net
Sandra Matsumoto,
sandramatsumoto@natura.net
Coordinators

This note contains forward-looking statements. Such statements are not statements of historical fact, and
reflect the beliefs and expectations of the Natura's management. The words "anticipates", "wishes", "expects",
"estimates", "intends", "forecasts", "plans", "predicts", "projects", "targets" and similar words are intended to
identify these statements, which necessarily involve known and unknown risks and uncertainties. Known risks
and uncertainties include, but are not limited to, the impact of competitive products and pricing, market
acceptance of products, product transitions by the Company and its competitors, regulatory approval, currency
fluctuations, production and supply difficulties, changes in product sales mix, and other risks. This press release
also includes proforma information prepared by the Company for information and reference purposes only,
which has not been audited. Forward-looking statements speak only as of the date they are made, and the
Company does not undertake any obligation to update them in light of new information or future developments.